Literature DB >> 24798328

Low density lipoprotein receptor class A repeats are O-glycosylated in linker regions.

Nis Borbye Pedersen1, Shengjun Wang1, Yoshiki Narimatsu1, Zhang Yang1, Adnan Halim1, Katrine Ter-Borch Gram Schjoldager1, Thomas Daugbjerg Madsen1, Nabil G Seidah2, Eric Paul Bennett1, Steven B Levery1, Henrik Clausen3.   

Abstract

The low density lipoprotein receptor (LDLR) is crucial for cholesterol homeostasis and deficiency in LDLR functions cause hypercholesterolemia. LDLR is a type I transmembrane protein that requires O-glycosylation for stable expression at the cell surface. It has previously been suggested that LDLR O-glycosylation is found N-terminal to the juxtamembrane region. Recently we identified O-glycosylation sites in the linker regions between the characteristic LDLR class A repeats in several LDLR-related receptors using the "SimpleCell" O-glycoproteome shotgun strategy. Herein, we have systematically characterized O-glycosylation sites on recombinant LDLR shed from HEK293 SimpleCells and CHO wild-type cells. We find that the short linker regions between LDLR class A repeats contain an evolutionarily conserved O-glycosylation site at position -1 of the first cysteine residue of most repeats, which in wild-type CHO cells is glycosylated with the typical sialylated core 1 structure. The glycosites in linker regions of LDLR class A repeats are conserved in LDLR from man to Xenopus and found in other homologous receptors. O-Glycosylation is controlled by a large family of polypeptide GalNAc transferases. Probing into which isoform(s) contributed to glycosylation of the linker regions of the LDLR class A repeats by in vitro enzyme assays suggested a major role of GalNAc-T11. This was supported by expression of LDLR in HEK293 cells, where knock-out of the GalNAc-T11 isoform resulted in the loss of glycosylation of three of four linker regions.
© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  GALNT; Glycosylation; Glycosyltransferase; Lectin; Lipoprotein Receptor-related Protein (LPR); Low Density Lipoprotein (LDL); O-Glycan; Zinc Finger Nuclease

Mesh:

Substances:

Year:  2014        PMID: 24798328      PMCID: PMC4067166          DOI: 10.1074/jbc.M113.545053

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  62 in total

1.  A UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase is required for epithelial tube formation.

Authors:  E Tian; Kelly G Ten Hagen
Journal:  J Biol Chem       Date:  2006-11-10       Impact factor: 5.157

2.  Bacterial glycosidases for the production of universal red blood cells.

Authors:  Qiyong P Liu; Gerlind Sulzenbacher; Huaiping Yuan; Eric P Bennett; Greg Pietz; Kristen Saunders; Jean Spence; Edward Nudelman; Steven B Levery; Thayer White; John M Neveu; William S Lane; Yves Bourne; Martin L Olsson; Bernard Henrissat; Henrik Clausen
Journal:  Nat Biotechnol       Date:  2007-04-01       Impact factor: 54.908

3.  Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry.

Authors:  Rui Chen; Xinning Jiang; Deguang Sun; Guanghui Han; Fangjun Wang; Mingliang Ye; Liming Wang; Hanfa Zou
Journal:  J Proteome Res       Date:  2009-02       Impact factor: 4.466

4.  Enrichment of glycopeptides for glycan structure and attachment site identification.

Authors:  Jonas Nilsson; Ulla Rüetschi; Adnan Halim; Camilla Hesse; Elisabet Carlsohn; Gunnar Brinkmalm; Göran Larson
Journal:  Nat Methods       Date:  2009-10-18       Impact factor: 28.547

5.  Initiation of protein O glycosylation by the polypeptide GalNAcT-1 in vascular biology and humoral immunity.

Authors:  Mari Tenno; Kazuaki Ohtsubo; Fred K Hagen; David Ditto; Alexander Zarbock; Patrick Schaerli; Ulrich H von Andrian; Klaus Ley; Dzung Le; Lawrence A Tabak; Jamey D Marth
Journal:  Mol Cell Biol       Date:  2007-10-08       Impact factor: 4.272

6.  Identification of a novel cancer-specific immunodominant glycopeptide epitope in the MUC1 tandem repeat.

Authors:  Mads A Tarp; Anne Louise Sørensen; Ulla Mandel; Hans Paulsen; Joy Burchell; Joyce Taylor-Papadimitriou; Henrik Clausen
Journal:  Glycobiology       Date:  2006-10-18       Impact factor: 4.313

Review 7.  The LDL receptor.

Authors:  Joseph L Goldstein; Michael S Brown
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-04       Impact factor: 8.311

8.  Conservation of peptide acceptor preferences between Drosophila and mammalian polypeptide-GalNAc transferase ortholog pairs.

Authors:  Thomas A Gerken; Kelly G Ten Hagen; Oliver Jamison
Journal:  Glycobiology       Date:  2008-07-31       Impact factor: 4.313

9.  Ablation of the Galnt3 gene leads to low-circulating intact fibroblast growth factor 23 (Fgf23) concentrations and hyperphosphatemia despite increased Fgf23 expression.

Authors:  Shoji Ichikawa; Andrea H Sorenson; Anthony M Austin; Donald S Mackenzie; Timothy A Fritz; Akira Moh; Siu L Hui; Michael J Econs
Journal:  Endocrinology       Date:  2009-02-12       Impact factor: 4.736

10.  Structural requirements for PCSK9-mediated degradation of the low-density lipoprotein receptor.

Authors:  Da-Wei Zhang; Rita Garuti; Wan-Jin Tang; Jonathan C Cohen; Helen H Hobbs
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-27       Impact factor: 11.205

View more
  24 in total

1.  Deconstruction of O-glycosylation--GalNAc-T isoforms direct distinct subsets of the O-glycoproteome.

Authors:  Katrine T Schjoldager; Hiren J Joshi; Yun Kong; Christoffer K Goth; Sarah Louise King; Hans H Wandall; Eric P Bennett; Sergey Y Vakhrushev; Henrik Clausen
Journal:  EMBO Rep       Date:  2015-11-13       Impact factor: 8.807

2.  Probing polypeptide GalNAc-transferase isoform substrate specificities by in vitro analysis.

Authors:  Yun Kong; Hiren J Joshi; Katrine Ter-Borch Gram Schjoldager; Thomas Daugbjerg Madsen; Thomas A Gerken; Malene B Vester-Christensen; Hans H Wandall; Eric Paul Bennett; Steven B Levery; Sergey Y Vakhrushev; Henrik Clausen
Journal:  Glycobiology       Date:  2014-08-25       Impact factor: 4.313

3.  Observing the nonvectorial yet cotranslational folding of a multidomain protein, LDL receptor, in the ER of mammalian cells.

Authors:  Hiroshi Kadokura; Yui Dazai; Yo Fukuda; Naoya Hirai; Orie Nakamura; Kenji Inaba
Journal:  Proc Natl Acad Sci U S A       Date:  2020-06-29       Impact factor: 11.205

4.  Discovery of O-glycans on atrial natriuretic peptide (ANP) that affect both its proteolytic degradation and potency at its cognate receptor.

Authors:  Lasse H Hansen; Thomas Daugbjerg Madsen; Christoffer K Goth; Henrik Clausen; Yang Chen; Nina Dzhoyashvili; Seethalakshmi R Iyer; S Jeson Sangaralingham; John C Burnett; Jens F Rehfeld; Sergey Y Vakhrushev; Katrine T Schjoldager; Jens P Goetze
Journal:  J Biol Chem       Date:  2019-06-11       Impact factor: 5.157

5.  Exploring Regulation of Protein O-Glycosylation in Isogenic Human HEK293 Cells by Differential O-Glycoproteomics.

Authors:  Yoshiki Narimatsu; Hiren J Joshi; Katrine T Schjoldager; John Hintze; Adnan Halim; Catharina Steentoft; Rebecca Nason; Ulla Mandel; Eric P Bennett; Henrik Clausen; Sergey Y Vakhrushev
Journal:  Mol Cell Proteomics       Date:  2019-04-30       Impact factor: 5.911

6.  Probing the contribution of individual polypeptide GalNAc-transferase isoforms to the O-glycoproteome by inducible expression in isogenic cell lines.

Authors:  John Hintze; Zilu Ye; Yoshiki Narimatsu; Thomas Daugbjerg Madsen; Hiren J Joshi; Christoffer K Goth; Adam Linstedt; Collin Bachert; Ulla Mandel; Eric P Bennett; Sergey Y Vakhrushev; Katrine T Schjoldager
Journal:  J Biol Chem       Date:  2018-10-16       Impact factor: 5.157

7.  Site-specific O-glycosylation of members of the low-density lipoprotein receptor superfamily enhances ligand interactions.

Authors:  Shengjun Wang; Yang Mao; Yoshiki Narimatsu; Zilu Ye; Weihua Tian; Christoffer K Goth; Erandi Lira-Navarrete; Nis B Pedersen; Asier Benito-Vicente; Cesar Martin; Kepa B Uribe; Ramon Hurtado-Guerrero; Christina Christoffersen; Nabil G Seidah; Rikke Nielsen; Erik I Christensen; Lars Hansen; Eric P Bennett; Sergey Y Vakhrushev; Katrine T Schjoldager; Henrik Clausen
Journal:  J Biol Chem       Date:  2018-03-20       Impact factor: 5.157

Review 8.  Polypeptide GalNAc-Ts: from redundancy to specificity.

Authors:  Matilde de Las Rivas; Erandi Lira-Navarrete; Thomas A Gerken; Ramon Hurtado-Guerrero
Journal:  Curr Opin Struct Biol       Date:  2019-01-28       Impact factor: 6.809

9.  Mucin-type O-glycosylation is controlled by short- and long-range glycopeptide substrate recognition that varies among members of the polypeptide GalNAc transferase family.

Authors:  Leslie Revoredo; Shengjun Wang; Eric Paul Bennett; Henrik Clausen; Kelley W Moremen; Donald L Jarvis; Kelly G Ten Hagen; Lawrence A Tabak; Thomas A Gerken
Journal:  Glycobiology       Date:  2015-11-26       Impact factor: 4.313

10.  Galnt11 regulates kidney function by glycosylating the endocytosis receptor megalin to modulate ligand binding.

Authors:  E Tian; Shengjun Wang; Liping Zhang; Ying Zhang; May C Malicdan; Yang Mao; Christina Christoffersen; Lawrence A Tabak; Katrine T Schjoldager; Kelly G Ten Hagen
Journal:  Proc Natl Acad Sci U S A       Date:  2019-11-18       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.